The foundational paper behind the dominant Alzheimer's theory, the amyloid beta model that has directed over $1.6 billion in NIH funding, appears to have been based on fabricated research images. The model may be built on fraud. Amyloid beta still dominates research and drug development anyway.

Scientists who have pursued other explanations, including immune dysfunction and inflammation, say they have been systematically shut out of funding by what researchers themselves are calling the "amyloid mafia." This has been a protected theory surrounded by the people who profit from it, not science.

Meanwhile, a 2022 precision medicine study went almost entirely unnoticed. Alzheimer's patients were treated for nine months with personalized protocols targeting each individual's contributing factors. At three months, they improved. At six months, they kept improving. At nine months, they kept improving. Cognitive scores went up. That was supposed to be impossible. The medical consensus has been that Alzheimer's is a one-way road and the best anyone can do is slow the decline.

The summary of all of this is exactly right: being healthy makes you healthier. That should not be breaking news. The fact that it is tells you everything about how this disease has been managed.

@delbigtree